StarkWare CEO proposes replacing Bitcoin’s 21 million supply cap with a 4% annual issuance rate
Odaily reported that StarkWare CEO Eli Ben-Sasson suggested replacing Bitcoin's hard cap of 21 million coins with a 4% annual issuance rate. He argued that the current hard cap is "unreasonable" because private keys will be lost over time — "as time tends toward infinity, all private keys will be lost." Ledger estimates that around 4 million Bitcoins have been permanently lost. Ben-Sasson stated that a 4% annual issuance rate roughly matches the global population growth rate. The proposal sparked opposition within the community, with critics arguing that the fixed cap is core to Bitcoin's value and that Bitcoin can be divided down to 2.1 trillion satoshi units, which is sufficient to address the issue of declining available supply.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).
Crypto prices
More
